Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pamapimod vs Methotrexate in Active Rheumatoid Arthritis
NCT00303563Phase 2Completed
- Sponsor
- Roche
- Start
- Apr 2006
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 2 trial of pamapimod in rheumatoid arthritis (RA), sponsored by Roche. Started Apr 2006; status: completed.
02
Drugs
pamapimod
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00303563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00303563.